WHO ICTRP trial

Shortened (hypofractionated) versus conventional radiotherapy in early breast…

DRKS00005618 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00005618
Public title Shortened (hypofractionated) versus conventional radiotherapy in early breast cancer after election by the patient
Scientific title Shortened (hypofractionated) versus conventional radiotherapy in early breast cancer after election by the patient - HypoChoice
Primary sponsor Universitätsklinikum DresdenKlinik für Strahlentherapie und Radioonkologie
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type observational
Countries Germany
Conditions C50;Malignant neoplasm of breast
Interventions Group 1: normofractionated radiotherapy (2 Gy per fraction, 25 fractions, duration 5 weeks, total dose 50 Gy (whole breast); in addition in invasive carcinomas boost with a total of 10 Gy in 5 fractions) Group 2: hypofractionated…
Registration date Jan 21, 2014
Target size 774
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations